December 28, 2014 12:37 AM ET

Life Sciences Tools and Services

Company Overview of PathoGenetix, Inc.

Executive Profile

Mark A. Peterson

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

----

Background

Mr. Mark A. Peterson served as the President of Ironwood Pharmaceuticals Inc. (formerly Microbia, Inc.) Mr. Peterson also served as President of Fidelity Biosciences Group at Fidelity Investments. Prior to assuming this responsibility, he served as President of Fidelity Corporate Systems and Processing, where he oversaw the delivery of a group of internal corporate services company-wide. Mr. Peterson also served as President of Fidelity Technology and Processing Group ...

Corporate Headquarters

12 Gill Street
Woburn, Massachusetts 01801

United States

Phone: 781-937-5550
Fax: 781-938-0060

Board Members Memberships

Former Director
Former Director
Former Director

Education

Bachelor's Degree
Pennsylvania State University
JD
Temple University School Of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PathoGenetix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.